Status:
TERMINATED
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
35-80 years
Phase:
PHASE3
Brief Summary
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents
Eligibility Criteria
Inclusion
- Diabetes mellitus type 2
- Failing two or more oral anti-diabetic agents
Exclusion
- Asthma, COPD
- Smoking
Key Trial Info
Start Date :
March 6 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 19 2008
Estimated Enrollment :
354 Patients enrolled
Trial Details
Trial ID
NCT00282971
Start Date
March 6 2006
End Date
February 19 2008
Last Update
April 2 2019
Active Locations (64)
Enter a location and click search to find clinical trials sorted by distance.
1
Gain Medical Center
Coquitlam, British Columbia, Canada, V3K 3P4
2
Misericordia Health Centre
Winnipeg, Manitoba, Canada, R3C 1A2
3
Maritime Research Center
Bathurst, New Brunswick, Canada, E2A 4X7
4
Office of Dr. Salim Sunderji
London, Ontario, Canada, N6P 1A9